July 11, 2018

Janelle Ayres receives $1 million from W. M. Keck Foundation for infectious disease research

Salk scientist who studies infectious diseases receives grant to investigate new approaches to tackle deadly bacterial and viral infections

Salk Nachrichten


Janelle Ayres receives $1 million from W. M. Keck Foundation for infectious disease research

Salk scientist who studies infectious diseases receives grant to investigate new approaches to tackle deadly bacterial and viral infections

LA JOLLA—Associate Professor Janelle Ayres is the recipient of a $1 million grant from the W. M. Keck Foundation to study new ways to treat deadly infections including sepsis and the flu, both of which require novel therapies beyond antibiotics and antivirals to effectively combat.

Janelle Ayres
Janelle Ayres

Klicken Sie hier für ein hochauflösendes Bild.

Kredit: Salk Institut

“Humanity is engaged in an escalating arms race with superbugs,” says Salk President Rusty Gage. “With antimicrobial resistance on the rise, Janelle’s groundbreaking work offers a shining ray of hope that effective new solutions for fighting infectious diseases are on the horizon.”

As a member of Salk’s NOMIS Center for Immunobiology and Microbial Pathogenesis, Ayres works at the intersection of immunology, metabolism and microbiology, studying how our bodies stay healthy during infections. She takes an innovative approach grounded in mathematical and evolutionary predictions to understand how bacteria have evolved ways to promote our health. She uses these discoveries to develop new therapies for treating diseases.

Ayres’ cutting-edge research on host-pathogen interactions is redefining health. In pivotal work, she discovered that microbes have evolved mechanisms to promote the health of the host to support their own survival, revealing a beneficial role for microbes in the maintenance of host health. Her revelation of an entirely new set of defense mechanisms may lead to novel therapies that bacteria won’t be able to evolve resistance to (unlike antibiotics). Ultimately, by leveraging those damage-control mechanisms, Ayres aims to develop effective treatments for infectious and noninfectious diseases, such as pathologies associated with cancer and aging.

Ayres, who is the Helen McLoraine Developmental Chair at Salk and a Searle Scholar, is also the recipient of a 2018 Blavatnik National Award for Young Scientists, a DARPA Young Faculty award and a Ray Thomas Edwards Foundation Award, among other honors.

About the W. M. Keck Foundation:

Based in Los Angeles, the W. M. Keck Foundation was established in 1954 by the late W. M. Keck, founder of the Superior Oil Company. The Foundation’s grant making is focused primarily on pioneering efforts in the areas of medical research, science and engineering and undergraduate education. The Foundation also maintains a Southern California Grant Program that provides support for the Los Angeles community, with a special emphasis on children and youth. For more information, please visit www.wmkeck.org.

Über das Salk Institute for Biological Studies:

Jede Heilung hat ihren Anfang. Das Salk Institute verkörpert Jonas Salks Mission, Träume kühn in die Realität umzusetzen. Seine international renommierten und preisgekrönten Wissenschaftler erforschen die fundamentalen Grundlagen des Lebens und suchen nach neuen Erkenntnissen in den Bereichen Neurowissenschaften, Genetik, Immunologie, Pflanzenbiologie und vielen mehr. Das Institut ist eine unabhängige gemeinnützige Organisation und ein architektonisches Wahrzeichen: bewusst klein, von Natur aus intim und furchtlos angesichts jeder Herausforderung. Ob Krebs oder Alzheimer, Altern oder Diabetes – am Salk Institute beginnen Heilungen. Erfahren Sie mehr unter: salk.edu.

Forschungsbereiche

Für weitere Informationen

Büro für Kommunikation
Telefon: (858) 453-4100
press@salk.edu

Das Salk-Institut für biologische Studien:

Das Salk Institute ist ein unabhängiges, gemeinnütziges Forschungsinstitut, das 1960 von Jonas Salk, dem Entwickler des ersten sicheren und wirksamen Polio-Impfstoffs, gegründet wurde. Die Aufgabe des Instituts besteht darin, grundlegende, kooperative und risikofreudige Forschung voranzutreiben, die sich mit den dringendsten Herausforderungen der Gesellschaft befasst, darunter Krebs, Alzheimer und die Gefährdung der Landwirtschaft. Diese Grundlagenforschung bildet die Basis für alle translationalen Bemühungen und führt zu Erkenntnissen, die neue Medikamente und Innovationen weltweit ermöglichen.